Sequential zoledronate therapy prevent rebound bone loss following withdrawal of RANKL inhibition

Albert Kim
Albert Kim

Albert Kim

Garvan Institute of Medical Research, Australia

© 2021-2023 – International Federation of Musculoskeletal Research Societies